AI | pharmaphorum

AI

Patients

pharmaphorum spoke with Leslie Oley Wilberforce, Evidation's new CEO, about the company's unique approach to real-world data and her future plans.

Market Access

What were the major themes to come out of BIO Boston 2025? Despite global events in the background, a fair amount of positivity.

Market Access

AI technologies can enable companies to program, rather than write, submissions to health authorities.

Digital

At BIO 2025, editor-in-chief Jonah Comstock spoke with Brian Alexander, CEO of Valo Health, about how he’s seeing the AI conversation evolve.

Digital

The industry must move beyond hype and address the real-world applications of AI for accurate enrolment forecasting.

Digital